$NSPR News
Last published 14h ago
- 14h agoNSPRInspireMD, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 8.01 Item 9.01
- 1d agoNSPRInspireMD Announces Updated Timing for Third Quarter 2026 Financial ResultsGlobeNewswireMIAMI, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced that it has rescheduled its third quarter 2026 financial results conference call and webcast to 4:30 p.m. Eastern Time, after the close of U.S. financial markets on Thursday, November 12, 2026, from its previously announced time ...
- 2w agoNSPRInspireMD to Announce Third Quarter 2026 Financial ResultsGlobeNewswireMIAMI, Oct. 29, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter
- 1mo agoNSPRInspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 MillionGlobeNewswire- Amendments align trigger event of existing warrants with anticipated FDA approval of CGuard Prime 80 cm, which the Company continues to anticipate in Q4 2026 - - The amended warrants, if exercised in full, together
- 2mo agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, Sept. 04, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced
- 2mo agoNSPRInspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment ConferenceGlobeNewswireMIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced
- 2mo agoNSPRInspireMD Reports Second Quarter 2026 Financial ResultsGlobeNewswire- Company to host investor conference call today, August 17th, at 8:30am EDT - MIAMI, Aug. 17, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the
- 3mo agoNSPRInspireMD to Announce Second Quarter 2026 Financial ResultsGlobeNewswireMIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced
- 3mo agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced
- 3mo agoNSPRInspireMD Appoints Carotid Intervention Commercial Leader Kathleen Kennedy as Senior Vice President of Global Sales and MarketingGlobeNewswireMIAMI, July 30, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced
- 5mo agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, June 12, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the
- 5mo agoNSPRInspireMD Announces 30-Day Results from the CGUARDIANS II Clinical Trial of the CGuard Prime 80 cm Implant for Use in TCAR ProceduresGlobeNewswireMIAMI, June 11, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced 30-day
- 5mo agoNSPRInspireMD Announces First Patient Enrolled in the CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System for Use in TCAR ProceduresGlobeNewswireMIAMI, June 08, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the
- 6mo agoNSPR2026 GLOBAL HEALTHCARE CONFERENCEINSPIREMD INCEarnings Call TranscriptsGood afternoon, everyone. My name is Aidan Leahy. I'm on the MedTech Research Team at Bank of America. Really excited to introduce InspireMD. We'll have Chief Communication Officer Shane Gleason come up to give a present
- 6mo agoNSPRInspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare ConferenceGlobeNewswireMIAMI, May 06, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to
- 6mo agoNSPRQ1 2026 InspireMD Earnings CallINSPIREMD INCEarnings Call TranscriptsGood morning and welcome to InspireMD's first quarter 2026 earnings conference call. Currently, all participants are in listen-only mode. We will facilitate a question-and-answer session towards the end of today's call.
- 6mo agoNSPRInspireMD Reports First Quarter 2026 Financial ResultsGlobeNewswire- Reports total Q1 2026 revenue of $3.4 million, representing year-over-year growth of 122% - - Received IDE approval from FDA to initiate the CGUARDIANS III clinical trial of its SwitchGuard neuro
- 6mo agoNSPRInspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection SystemGlobeNewswireMIAMI, May 01, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the U.S.
- 6mo agoNSPRInspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery SystemGlobeNewswire- Strong clinical demand continues in Q1 2026 with global year-over-year unit sales growth of 53% and quarter-over-quarter U.S. unit sales growth of 34% - - FDA approval anticipated with U.S. market availability of
- 6mo agoNSPRInspireMD to Announce First Quarter 2026 Financial ResultsGlobeNewswireMIAMI, April 27, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its first quarter
- 7mo agoNSPRInspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare ConferenceGlobeNewswireMIAMI, March 31, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming 25th
- 8mo agoNSPRInspireMD to Announce Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswireMIAMI, March 09, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its fourth quarter
- 9mo agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the
- 10mo agoNSPRInspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)GlobeNewswireThe CGuard® Prime Carotid Stent System demonstrated the lowest 30-day and 1-year primary endpoint major adverse event rates of any pivotal study of carotid stenting (CAS) MIAMI, Jan. 12, 2026 (GLOBE NEWSWIRE) --
- 11mo agoNSPRLandmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery StentingGlobeNewswireMIAMI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, welcomes the recent
- 11mo agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, Nov. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the
- 11mo agoNSPRInspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireMIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside
- 1y agoNSPRInspireMD Reports Third Quarter 2025 Financial ResultsGlobeNewswireMIAMI, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced financial
- 1y agoNSPRInspireMD Names Peter A. Soukas, M.D., as Chief Medical OfficerGlobeNewswireMIAMI, Nov. 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the
- 1y agoNSPRInspireMD to Announce Third Quarter 2025 Financial ResultsGlobeNewswireMIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025
- 1y agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, Oct. 08, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that the
- 1y agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, Sept. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc.
- 1y agoBBNXNSPRInspireMD Announces the Appointment of Dan Dearen to its Board of DirectorsGlobeNewswireMIAMI, Sept. 17, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the
- 1y agoNSPRInspireMD to Present at Upcoming H.C. Wainwright 27th Annual Global Investment ConferenceGlobeNewswireMIAMI, Aug. 27, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced plans to present at the upcoming H.C.
- 1y agoKMTSNSPRRXSTBiobeat Technologies Names Raymond W. Cohen as Chairman of the Board of DirectorsBusiness WireBiobeat Technologies Ltd, a medical device company that has developed a wearable cuff-less ambulatory blood pressure monitoring system that records and analyzes numerous physiological parameters, today announced the
- 1y agoNSPRInspireMD, Inc. (NSPR) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoNSPRInspireMD Reports Second Quarter 2025 Financial ResultsGlobeNewswire--- Management to host investor conference call today, August 5th, at 8:30am ET --- MIAMI, Aug. 05, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system
- 1y agoAXNXKMTSNSPRRXSTRxSight, Inc. Appoints Raymond W. Cohen to Its Board of DirectorsGlobeNewswireALISO VIEJO, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery,
- 1y agoKMTSNSPRInspireMD Announces the Appointment of Raymond W. Cohen to its Board of DirectorsGlobeNewswireMIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the
- 1y agoNSPRInspireMD Announces Combined Financings of $58 MillionGlobeNewswireMIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the Company
- 1y agoNSPRInspireMD to Announce Second Quarter 2025 Financial ResultsGlobeNewswireMIAMI, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its second
- 1y agoNSPRInspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of StrokeGlobeNewswireMIAMI, June 24, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (the "Company") (NASDAQ:NSPR), developer of the CGuard Prime Carotid Stent System for the prevention of stroke, today announced that the U.S. Food and Drug
- 1y agoNSPRInspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of StrokeGlobeNewswireMIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval
- 1y agoNSPRInspireMD Announces Appointment of Michael Lawless as Chief Financial OfficerGlobeNewswireMIAMI, June 03, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced
- 1y agoNSPRInspireMD Reports First Quarter 2025 Financial ResultsGlobeNewswireMIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced
- 1y agoNSPRInspireMD to Present at Upcoming Bank of America 2025 Healthcare ConferenceGlobeNewswireMIAMI, April 30, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced
- 1y agoNSPRInspireMD to Announce First Quarter 2025 Financial ResultsGlobeNewswireMIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease (CAD) and prevention of stroke, today
- 1y agoNSPRInspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswireMIAMI, April 08, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the prevention of stroke, today announced that the Compensation Committee of
- 1y agoNSPRInspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare ConferenceGlobeNewswireMIAMI, March 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced
- 1y agoNSPRInspireMD Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireMIAMI, March 12, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NASDAQ:NSPR), developer of the CGuard™ Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today announced